ERBB2 and neoplasm: In this paper, we studied in live animal, the difference in the lifetime of HER2-specific Affibody conjugated with the Dylight 750 fluorescent probe bound to target receptors at the tumor site, to the lifetime of unbound probes (at the contralateral side) for six different human cell lines with different level of HER2 expression.